Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics.

Véronique DiérasHervé BonnefoiEmilio AlbaAhmad AwadaBruno CoudertXavier PivotJoseph GligorovAgnes JagerStefania ZambelliGeoffrey J LindemanEric CharpentierGary T EmmonsIgnacio Garcia-RibasRobert ParidaensJaap Verweij

Published in: Breast cancer research and treatment (2019)

ClinicalTrial.gov Identifier NCT01045304.

Keyphrases

phase ii
open label
phase iii
phase ii study
clinical trial
placebo controlled
double blind
study protocol
randomized controlled trial
squamous cell carcinoma
rectal cancer